{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:06:12Z","timestamp":1773810372397,"version":"3.50.1"},"reference-count":82,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Science and Technology Development Foundation of Nanjing Medical University","award":["NMUB20210108"],"award-info":[{"award-number":["NMUB20210108"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82204469"],"award-info":[{"award-number":["NSFC82204469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,5]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Preterm birth (PTB) is a major cause of neonatal morbidity and mortality worldwide. Effective use of tocolytic agents may improve perinatal outcomes. This study aims to compare the effectiveness and safety of nifedipine and magnesium sulfate in the treatment of PTB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>China National Knowledge Infrastructure, China Science and Technology Journal Database, WanFang, PubMed, Embase, Web of Science and Cochrane were searched from inception to 1 December 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>We included randomised controlled trials (RCTs) and cohort studies that compare the efficacy and safety of magnesium sulfate versus nifedipine in treating PTB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two researchers independently screened studies and extracted data. Risk of bias was assessed using the Cochrane risk-of-bias assessment tool for RCTs and the modified Newcastle-Ottawa Scale for non-randomised studies. Meta-analysis was conducted using Review Manager V.5.4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In all, 50 articles were included in this review, comprising 6072 cases (n=3014 for the magnesium sulfate group; n=3058 for the nifedipine group). Compared with the magnesium sulfate group, the nifedipine group was more favourable in terms of time to onset of action and prolongation of days of gestation, as well as higher neonatal 1\u2009min Apgar scores. The use of magnesium sulfate was associated with a higher incidence of maternal side effects, specifically tachycardia, flushing, palpitations, dizziness and nausea. In addition, the magnesium sulfate group also showed a higher incidence of neonatal respiratory distress syndrome than the nifedipine group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared with magnesium sulfate, nifedipine is more effective with a faster onset of action and a longer prolonging pregnancy. Additionally, nifedipine may be safer for fewer maternal side effects and better neonatal outcomes. Further studies are needed to confirm the long-term safety and efficacy of these treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-085938","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:35:31Z","timestamp":1740263731000},"page":"e085938","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative effectiveness and safety of nifedipine and magnesium sulfate as treatment options for preterm birth: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5279-6993","authenticated-orcid":false,"given":"Jianing","family":"Fan","sequence":"first","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Lu","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Lin","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-1832","authenticated-orcid":false,"given":"Chong","family":"Fan","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Lyv","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"2025121602044784000_15.2.e085938.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.04.021"},{"key":"2025121602044784000_15.2.e085938.2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"The Lancet"},{"key":"2025121602044784000_15.2.e085938.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(21)00311-4"},{"key":"2025121602044784000_15.2.e085938.4","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/S0140-6736(23)00354-9","article-title":"Small vulnerable newborns\u2014big potential for impact","volume":"401","author":"Ashorn","year":"2023","journal-title":"The Lancet"},{"key":"2025121602044784000_15.2.e085938.5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/14740338.2016.1187128","article-title":"The safety of tocolytics used for the inhibition of preterm labour","volume":"15","author":"Lamont","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"2025121602044784000_15.2.e085938.6","article-title":"Tocolytics for delaying preterm birth: a network meta-analysis (0924)","volume":"8","author":"Wilson","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121602044784000_15.2.e085938.7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajog.2010.11.038","article-title":"Nifedipine in the management of preterm labor: a systematic review and metaanalysis","volume":"204","author":"Conde-Agudelo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2025121602044784000_15.2.e085938.8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/AOG.0000000000004436","article-title":"Nifedipine for Acute Tocolysis of Preterm Labor: A Placebo-Controlled Randomized Trial","volume":"138","author":"Hawkins","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025121602044784000_15.2.e085938.9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ogc.2005.03.002","article-title":"Magnesium sulfate: the first-line tocolytic","volume":"32","author":"Lewis","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2025121602044784000_15.2.e085938.10","article-title":"Magnesium sulphate for preventing preterm birth in threatened preterm labour","volume":"2014","author":"Crowther","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121602044784000_15.2.e085938.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002988","article-title":"Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis","volume":"16","author":"Shepherd","year":"2019","journal-title":"PLoS Med"},{"key":"2025121602044784000_15.2.e085938.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025121602044784000_15.2.e085938.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2025121602044784000_15.2.e085938.14","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The newcastle-ottawa scale (NOS) for assessing the quality of non-randomised studies in meta-analyses [EB\/OL]. 2014. Available: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2025121602044784000_15.2.e085938.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.015"},{"key":"2025121602044784000_15.2.e085938.16","first-page":"37","article-title":"The Effect of Different Uterine Contraction Inhibitors in the Treatment of Threatened Preterm Delivery and Its Effect on Pregnancy Outcome","volume":"17","author":"Yang","year":"2020","journal-title":"Med Innov China"},{"key":"2025121602044784000_15.2.e085938.17","first-page":"957","article-title":"Study of the clinical efficacy and safety of different tocolytics in treatment of threatened preterm labor","volume":"28","author":"Ye","year":"2017","journal-title":"Chin J Woman Child Health Res"},{"key":"2025121602044784000_15.2.e085938.18","first-page":"1327","article-title":"The Effect of Different Uterine Contraction Inhibitors in the Treatment of Threatened Preterm Delivery and Its Effect on Maternal and Perinatal Outcome","volume":"33","author":"Liu","year":"2020","journal-title":"Heilongjiang Med J"},{"key":"2025121602044784000_15.2.e085938.19","unstructured":"Haung S . The Effect of Different Uterine Contraction Inhibitors in the Treatment of Threatened Preterm Delivery. Med Health 2021;07\u20139."},{"key":"2025121602044784000_15.2.e085938.20","unstructured":"Tao X . To analyze the efficacy of different tocolytic agents in the treatment of patients with threatened preterm labor and the effects on maternal and perinatal outcomes. Home Med 2019;44\u20135."},{"key":"2025121602044784000_15.2.e085938.21","unstructured":"Deng Y . Comparisonof efficacy and safety of Ritodrine, nifedipine and magnesium sulfate in the treatment of threatened preterm labor. Health Guide 2019;223."},{"key":"2025121602044784000_15.2.e085938.22","unstructured":"Wang Y . Comparison of several inhibitors of uterine contraction in the treatment of thretened premature labor[D\/OL]. Shandong Shandong University; 2015."},{"key":"2025121602044784000_15.2.e085938.23","first-page":"87","article-title":"Clinical efficacy analysis of Ritodrine, nifedipine and magnesium sulfate in the treatment of threatened premature labor","volume":"18","author":"Jiang","year":"2020","journal-title":"Med Diet Health"},{"key":"2025121602044784000_15.2.e085938.24","first-page":"159","article-title":"Clinical study on the therapeutic effect of Ritodrine, nifedipine and magnesium sulfate on threatened premature labor","volume":"10","author":"Ding","year":"2020","journal-title":"Med Front"},{"key":"2025121602044784000_15.2.e085938.25","unstructured":"He L . Clinical study on the therapeutic effect of Ritodrine, Nifedipine and magnesium sulfate on threatened premature labor. Spec Health 2019;73\u20134."},{"key":"2025121602044784000_15.2.e085938.26","first-page":"62","article-title":"Clinical study on the therapeutic effect of Ritodrine, nifedipine and magnesium sulfate on threatened preterm labor","volume":"7","author":"Liu","year":"2017","journal-title":"Med Front"},{"key":"2025121602044784000_15.2.e085938.27","unstructured":"Wang H . Clinical studies ritodrine, nifedipine, magnesium sulfate for treatment of threatened premature[D\/OL]. Shandong Shandong University; 2014."},{"key":"2025121602044784000_15.2.e085938.28","unstructured":"Pan D . Clinical study on the therapeutic effect of ritodrine, nifedipine and magnesium sulfate on threatened premature labor. Med Health 2021;8\u20139."},{"key":"2025121602044784000_15.2.e085938.29","first-page":"75","article-title":"Comparison of effects of magnesium sulfate, Ritodrine and nifedipine on pregnancy outcomes and neonatal conditions in pregnant women with threatened preterm labor","volume":"26","author":"Li","year":"2022","journal-title":"Self Care"},{"key":"2025121602044784000_15.2.e085938.30","first-page":"41","article-title":"Comparison of clinical effect of magnesium sulfate, Ritodrine and nifedipine in the treatment of threatened premature labor","volume":"33","author":"Zeng","year":"2022","journal-title":"Mod Diagn Treat"},{"key":"2025121602044784000_15.2.e085938.31","first-page":"2038","article-title":"Study on the effect of three kinds of fetal saving drugs in the treatment of threatened preterm labor","volume":"38","author":"Han","year":"2016","journal-title":"Hebei Med"},{"key":"2025121602044784000_15.2.e085938.32","first-page":"10695","article-title":"Comparison of the effects of different drugs for fetal preservation in threatened preterm labor","volume":"3","author":"Cheng","year":"2016","journal-title":"EClinicalMedicine"},{"key":"2025121602044784000_15.2.e085938.33","first-page":"416","article-title":"Clinical study on the therapeutic effect of ritodrine, nifedipine and magnesium sulfate on preterm labor","volume":"28","author":"Wang","year":"2017","journal-title":"Chin J Woman Child Health Res"},{"key":"2025121602044784000_15.2.e085938.34","unstructured":"Li T . Clinical efficacy and incidence of adverse outcomes in the treatment of threatened premature labor with ritodrine, nifedipine and magnesium sulfate. Chin Baby 2021;95."},{"key":"2025121602044784000_15.2.e085938.35","unstructured":"Lv X . Effect of nifedipine on premature labor. Chin J Med 2016;96\u20137."},{"key":"2025121602044784000_15.2.e085938.36","first-page":"12","article-title":"Clinical observation of Nifedipine in prevention and treatment of premature labor","volume":"7","author":"Yue","year":"2015","journal-title":"China Rural Health"},{"key":"2025121602044784000_15.2.e085938.37","unstructured":"Chen T . Comparison of clinical effect of nifedipine and magnesium sulfate in the treatment of threatened premature labor. Spec Health 2020;15."},{"key":"2025121602044784000_15.2.e085938.38","unstructured":"Peng D . Comparison of clinical effect of nifedipine and magnesium sulfate in the treatment of threatened premature labor. Med Health 2021;48\u20139."},{"key":"2025121602044784000_15.2.e085938.39","first-page":"152","article-title":"Comparison of efficacy of nifedipine and magnesium sulfate in the treatment of threatened premature labor","volume":"6","author":"Chen","year":"2019","journal-title":"J Gynaecol Endocrinol"},{"key":"2025121602044784000_15.2.e085938.40","first-page":"93","article-title":"Clinical Comparison of Nifedipine and Magnesium Sulfate in Treatment of Premature birth","volume":"11","author":"Huang","year":"2014","journal-title":"Med Innov China"},{"key":"2025121602044784000_15.2.e085938.41","unstructured":"Sun M . Comparison of clinical effect of nifedipine and magnesium sulfate on premature labor. Med Inform 2015;202."},{"key":"2025121602044784000_15.2.e085938.42","first-page":"78","article-title":"Clinical efficacy comparison of Nifedipine and Magnesium Sulfate in the treatment of preterm labor","volume":"16","author":"Yang","year":"2019","journal-title":"China Med Herald"},{"key":"2025121602044784000_15.2.e085938.43","first-page":"82","article-title":"Efficacy comparison of nifedipine and magnesium sulfate in the treatment of premature labor","volume":"20","author":"Yang","year":"2013","journal-title":"China Mod Med"},{"key":"2025121602044784000_15.2.e085938.44","first-page":"118","article-title":"Clinical efficacy evaluation of nifedipine and magnesium sulfate in the treatment of premature labor","volume":"32","author":"Qing","year":"2022","journal-title":"China Health Care Nutr"},{"key":"2025121602044784000_15.2.e085938.45","first-page":"99","article-title":"Clinical application of nifedipine in prevention and treatment of premature labor","volume":"37","author":"Pen","year":"2013","journal-title":"J Baotou Med"},{"key":"2025121602044784000_15.2.e085938.46","first-page":"324","article-title":"Analysis of theraputic effect of nifedipine in the treatment of threatened premature labor","volume":"27","author":"Li","year":"2017","journal-title":"China Health Care Nutr"},{"key":"2025121602044784000_15.2.e085938.47","unstructured":"Chen L , Chen Q , Song X . Analysis of clinical effect of nifedipine in the treatment of threatened premature labor. Spec Health 2022;58\u201360."},{"key":"2025121602044784000_15.2.e085938.48","first-page":"110","article-title":"Effect observation of Nifedipine treating threatened premature labor","volume":"24","author":"Zhu","year":"2017","journal-title":"China Mod Med"},{"key":"2025121602044784000_15.2.e085938.49","first-page":"85","article-title":"Clinical observation of nifedipine in the treatment of premature labor","volume":"34","author":"Cui","year":"2007","journal-title":"Cent Plains Med J"},{"key":"2025121602044784000_15.2.e085938.50","first-page":"165","article-title":"Clinical observation of nifedipine in the treatment of premature labor","volume":"4","author":"Liang","year":"2014","journal-title":"China Pract Med"},{"key":"2025121602044784000_15.2.e085938.51","unstructured":"Wei Q , Yang Y , Wei W . Clinical efficacy and safety of ritodrine, magnesium sulfate and nifedipine in the treatment of threatened premature labor. Health Guide 2022;25\u20138."},{"key":"2025121602044784000_15.2.e085938.52","first-page":"115","article-title":"Inhibitory effect of Ritodrine Hydrochloride, Nifedipine and Magnesium Sulfate on uterine contraction in pregnant woman with threatened premature labor and its effects on heart rate, blood pressure and pregnancy outcome","volume":"13","author":"Shi","year":"2018","journal-title":"China Pract Med"},{"key":"2025121602044784000_15.2.e085938.53","first-page":"123","article-title":"A comparative study between Nifedipine and magnesium sulfate for treatment of preterm birth","volume":"09","author":"Vimlesh","year":"2022","journal-title":"Eur J Mol Clin Med"},{"key":"2025121602044784000_15.2.e085938.54","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.847416"},{"key":"2025121602044784000_15.2.e085938.55","unstructured":"Tabassum S , Shahzadi U , Khalid A . Comparative Study of Efficacy of Magnesium Sulfate and Nifedipine in Suppression of Preterm Labor. PJMHS 2016;10."},{"key":"2025121602044784000_15.2.e085938.56","first-page":"136","article-title":"Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor","volume":"12","author":"Taherian","year":"2007","journal-title":"J Res Med Sci"},{"key":"2025121602044784000_15.2.e085938.57","unstructured":"Faisal J , Kanwal S , Inayat FC , et al . Comparison of Magnesium Sulfate and Nifedipine for the Management of Preterm Labour. PJMHS 2020;14."},{"key":"2025121602044784000_15.2.e085938.58","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3109\/14767058.2012.714819","article-title":"Effect of antenatal tocolysis on neonatal outcomes","volume":"25","author":"Klauser","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121602044784000_15.2.e085938.59","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(93)90035-H","article-title":"Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study","volume":"169","author":"Glock","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2025121602044784000_15.2.e085938.60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.15296\/ijwhr.2014.23","article-title":"Fetal & Neonatal Outcomes of the Magnesium Sulfate and Nefidipine in Suppression of Preterm Labor","volume":"2","author":"Sehhati Shafaie","year":"2014","journal-title":"IJWHR"},{"key":"2025121602044784000_15.2.e085938.61","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000269048.06634.35"},{"key":"2025121602044784000_15.2.e085938.62","first-page":"145","article-title":"Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial","volume":"12","author":"Nikbakht","year":"2014","journal-title":"Iran J Reprod Med"},{"key":"2025121602044784000_15.2.e085938.63","doi-asserted-by":"crossref","unstructured":"Khooshideh M , Rahmati J , Teimoori B . Nifedipine Versus Magnesium Sulfate for Treatment of Preterm Labor: Comparison of Efficacy and Adverse Effects in a Randomized Controlled Trial. Shiraz E-Med J 2017;18. doi:10.5812\/semj.46875","DOI":"10.5812\/semj.46875"},{"key":"2025121602044784000_15.2.e085938.64","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70388-1"},{"key":"2025121602044784000_15.2.e085938.65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0020-7292(99)00095-8","article-title":"Prevention of preterm delivery: nifedipine or magnesium sulfate","volume":"66","author":"Haghighi","year":"1999","journal-title":"Intl J Gynecol Obste"},{"key":"2025121602044784000_15.2.e085938.66","unstructured":"Yin S . Analysis of the efficacy and safety of nifedipine in the treatment of premature birth. Electr J Pract Gynecol Endocrinol 2023;10."},{"key":"2025121602044784000_15.2.e085938.67","unstructured":"Wei M , Li Y , Xu C . Effects of Ritodrine, nifedipine and magnesium sulfate on fetal preservation in patients with threatened premature delivery. Electr J Pract Gynecol Endocrinol 2023;20."},{"key":"2025121602044784000_15.2.e085938.68","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-021-00328-7"},{"key":"2025121602044784000_15.2.e085938.69","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31817c50fc"},{"key":"2025121602044784000_15.2.e085938.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.02.050"},{"key":"2025121602044784000_15.2.e085938.71","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b48336"},{"key":"2025121602044784000_15.2.e085938.72","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(16)00590-0","article-title":"Tocolysis and preterm labour","volume":"387","author":"Walker","year":"2016","journal-title":"The Lancet"},{"key":"2025121602044784000_15.2.e085938.73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00286","article-title":"Discovery and Development of Calcium Channel Blockers","volume":"8","author":"Godfraind","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025121602044784000_15.2.e085938.74","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.314202"},{"key":"2025121602044784000_15.2.e085938.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.05.004"},{"key":"2025121602044784000_15.2.e085938.76","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.6.639"},{"key":"2025121602044784000_15.2.e085938.77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00404-018-4839-9","article-title":"An effect of maternal nifedipine therapy on fetoplacental blood flow: a prospective study","volume":"298","author":"Namazov","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2025121602044784000_15.2.e085938.78","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ajog.2015.12.060","article-title":"Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women","volume":"214","author":"Brookfield","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025121602044784000_15.2.e085938.79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajog.2011.01.046","article-title":"Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate","volume":"204","author":"Greenberg","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2025121602044784000_15.2.e085938.80","article-title":"Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour","volume":"2013","author":"Han","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121602044784000_15.2.e085938.81","unstructured":"Roos C , Spaanderman MEA , Schuit E , et al . Effect of Maintenance Tocolysis With Nifedipine in Threatened Preterm Labor on Perinatal Outcomes. J Am Med Assoc 2013;309."},{"key":"2025121602044784000_15.2.e085938.82","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jogc.2018.09.018","article-title":"SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection","volume":"41","author":"Magee","year":"2019","journal-title":"J Obstet Gynaecol Can"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-085938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:05:03Z","timestamp":1765879503000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-085938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":82,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,22]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-085938"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085938","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}